Table 5. Total cost distribution per cancer location for patients accounted for the economic analysis—i.e. with a first hospital admission for potentially HPV-related cancer of interest in 2011, to the exclusion of patients with another primary tumour—within the 3 years after cancer diagnosis.

	Cervical cancer	Vulvar cancer	Vaginal cancer	Anal cancer	Oral cancer	Oropharyngeal cancer
Hospitalization (€, total)	63,176,657	8,530,148	4,958,878	25,608,046	74,162,931	135,806,176
Surgery	14,547,253	2,905,665	709,212	4,726,047	22,868,744	19,306,984
Chemotherapy	15,934,772	1,281,989	1,152,349	6,657,740	16,882,862	44,656,453
Radiotherapy	8,423,416	781,925	844,588	4,006,579	6,257,942	13,642,448
Palliative care	7,282,808	1,435,552	701,102	2,368,929	7,300,735	13,712,741
Other hospitalizations	16,988,406	2,125,017	1,551,627	7,848,754	20,852,647	44,487,551
Outpatient care costs	34,939,779	4,717,590	2,742,502	14,162,501	41,015,726	75,107,454
Disability allowances	5,153,695	695,855	404,525	2,089,001	6,049,910	11,078,516
Total costs	103,270,131	13,943,593	8,105,905	41,859,548	121,228,567	221,992,147